第一選択治療としての慢性骨髄性白血病におけるニロチニブとイマチニブの有効性と安全性【Powered by NICT】
2015
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
Old Web
English
Sign In
Email Address
acemap@cs.sjtu.edu.cn
- CCF Conference Analysis
- Map Galaxy
- Academic Report
- What's New
© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.